These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34828406)

  • 1. DYRK1A Overexpression in Mice Downregulates the Gonadotropic Axis and Disturbs Early Stages of Spermatogenesis.
    Dard R; Moreau M; Parizot E; Ghieh F; Brehier L; Kassis N; Serazin V; Lamaziere A; Racine C; di Clemente N; Vialard F; Janel N
    Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DYRK1A BAC transgenic mouse: a new model of thyroid dysgenesis in Down syndrome.
    Kariyawasam D; Rachdi L; Carré A; Martin M; Houlier M; Janel N; Delabar JM; Scharfmann R; Polak M
    Endocrinology; 2015 Mar; 156(3):1171-80. PubMed ID: 25490145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndrome.
    García-Cerro S; Martínez P; Vidal V; Corrales A; Flórez J; Vidal R; Rueda N; Arbonés ML; Martínez-Cué C
    PLoS One; 2014; 9(9):e106572. PubMed ID: 25188425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations.
    Toiber D; Azkona G; Ben-Ari S; Torán N; Soreq H; Dierssen M
    Neurobiol Dis; 2010 Oct; 40(1):348-59. PubMed ID: 20600907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DYRK1A-mediated Cyclin D1 Degradation in Neural Stem Cells Contributes to the Neurogenic Cortical Defects in Down Syndrome.
    Najas S; Arranz J; Lochhead PA; Ashford AL; Oxley D; Delabar JM; Cook SJ; Barallobre MJ; Arbonés ML
    EBioMedicine; 2015; 2(2):120-34. PubMed ID: 26137553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyrk1A is dynamically expressed on subsets of motor neurons and in the neuromuscular junction: possible role in Down syndrome.
    Arque G; Casanovas A; Dierssen M
    PLoS One; 2013; 8(1):e54285. PubMed ID: 23342120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice.
    Mazur-Kolecka B; Golabek A; Kida E; Rabe A; Hwang YW; Adayev T; Wegiel J; Flory M; Kaczmarski W; Marchi E; Frackowiak J
    J Neurosci Res; 2012 May; 90(5):999-1010. PubMed ID: 22252917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndrome.
    Lepagnol-Bestel AM; Zvara A; Maussion G; Quignon F; Ngimbous B; Ramoz N; Imbeaud S; Loe-Mie Y; Benihoud K; Agier N; Salin PA; Cardona A; Khung-Savatovsky S; Kallunki P; Delabar JM; Puskas LG; Delacroix H; Aggerbeck L; Delezoide AL; Delattre O; Gorwood P; Moalic JM; Simonneau M
    Hum Mol Genet; 2009 Apr; 18(8):1405-14. PubMed ID: 19218269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DYRK1A overexpression decreases plasma lecithin:cholesterol acyltransferase activity and apolipoprotein A-I levels.
    Tlili A; Noll C; Middendorp S; Duchon A; Jouan M; Benabou E; Hérault Y; Paul JL; Delabar JM; Janel N
    Mol Genet Metab; 2013 Nov; 110(3):371-7. PubMed ID: 23920041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of DYRK1A, a Down Syndrome Candidate gene, Impairs Primordial Germ Cells Maintenance and Migration in zebrafish.
    Liu Y; Lin Z; Liu M; Wang H; Sun H
    Sci Rep; 2017 Nov; 7(1):15313. PubMed ID: 29127398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome.
    Dowjat WK; Adayev T; Kuchna I; Nowicki K; Palminiello S; Hwang YW; Wegiel J
    Neurosci Lett; 2007 Feb; 413(1):77-81. PubMed ID: 17145134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyrk1A phosphorylates p53 and inhibits proliferation of embryonic neuronal cells.
    Park J; Oh Y; Yoo L; Jung MS; Song WJ; Lee SH; Seo H; Chung KC
    J Biol Chem; 2010 Oct; 285(41):31895-906. PubMed ID: 20696760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model.
    Kurabayashi N; Nguyen MD; Sanada K
    EMBO Rep; 2015 Nov; 16(11):1548-62. PubMed ID: 26373433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome.
    Wegiel J; Dowjat K; Kaczmarski W; Kuchna I; Nowicki K; Frackowiak J; Mazur Kolecka B; Wegiel J; Silverman WP; Reisberg B; Deleon M; Wisniewski T; Gong CX; Liu F; Adayev T; Chen-Hwang MC; Hwang YW
    Acta Neuropathol; 2008 Oct; 116(4):391-407. PubMed ID: 18696092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Dyrk1A with AAVshRNA attenuates motor alterations in TgDyrk1A, a mouse model of Down syndrome.
    Ortiz-Abalia J; Sahún I; Altafaj X; Andreu N; Estivill X; Dierssen M; Fillat C
    Am J Hum Genet; 2008 Oct; 83(4):479-88. PubMed ID: 18940310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome.
    Altafaj X; Dierssen M; Baamonde C; Martí E; Visa J; Guimerà J; Oset M; González JR; Flórez J; Fillat C; Estivill X
    Hum Mol Genet; 2001 Sep; 10(18):1915-23. PubMed ID: 11555628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene dosage-dependent association of DYRK1A with the cytoskeleton in the brain and lymphocytes of down syndrome patients.
    Dowjat K; Adayev T; Kaczmarski W; Wegiel J; Hwang YW
    J Neuropathol Exp Neurol; 2012 Dec; 71(12):1100-12. PubMed ID: 23147510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic mouse in vivo library of human Down syndrome critical region 1: association between DYRK1A overexpression, brain development abnormalities, and cell cycle protein alteration.
    Branchi I; Bichler Z; Minghetti L; Delabar JM; Malchiodi-Albedi F; Gonzalez MC; Chettouh Z; Nicolini A; Chabert C; Smith DJ; Rubin EM; Migliore-Samour D; Alleva E
    J Neuropathol Exp Neurol; 2004 May; 63(5):429-40. PubMed ID: 15198122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
    Altafaj X; Martín ED; Ortiz-Abalia J; Valderrama A; Lao-Peregrín C; Dierssen M; Fillat C
    Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.